Characteristics of deslanoside-induced modulation on jejunal contractility

Figure 3 Effects of deslanoside on the contractility of jejunal smooth muscle fragment pretreated with tetrodotoxin. A: Representative traces of deslanoside on the contractility of jejunal smooth muscle fragment (JSMF) pre-treated with tetrodotoxin in normal contractile state (NCS), representative low contractile state (RLCS) and representative high contractile state (RHCS); B: Statistical analysis obtained from independent assays. Other data are the relative values compared with NCS. Data are expressed as the mean ± SE (%NCS, n = 6); ^aP < 0.05, ^bP < 0.01 vs contractile amplitude of JSMF after treatment with tetrodotoxin (TTX), (0.1 μmol/L).